These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1287622

  • 1. Comprehensive safety profile of cefaclor AF in respiratory, urinary tract and skin infections.
    Stotka JL, Senetar JE, Therasse DG, Dere WH.
    Postgrad Med J; 1992; 68 Suppl 3():S73-7; discussion S78-80. PubMed ID: 1287622
    [Abstract] [Full Text] [Related]

  • 2. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A, Longest KA, Senetar JE, Dere WH.
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of cefaclor AF in the treatment of skin and skin-structure infections.
    Schupbach CW, Olovich KG, Dere WH.
    Clin Ther; 1992; 14(3):470-9. PubMed ID: 1638588
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A.
    Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cefaclor--summary of clinical experience.
    Kammer RB, Short LJ.
    Postgrad Med J; 1979; 55 Suppl 4():93-9. PubMed ID: 548945
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cefaclor revisited.
    Meyers BR.
    Clin Ther; 2000 Feb; 22(2):154-66. PubMed ID: 10743978
    [Abstract] [Full Text] [Related]

  • 13. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Ruoff GE.
    Clin Ther; 1992 Feb; 14(1):41-53. PubMed ID: 1576625
    [Abstract] [Full Text] [Related]

  • 14. Therapy with cefaclor: analysis of infections in 189 French patients.
    Masbernard A, Salord JC.
    Postgrad Med J; 1979 Feb; 55 Suppl 4():72-6. PubMed ID: 398484
    [No Abstract] [Full Text] [Related]

  • 15. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C, Li J, Hou J, Guo M, Zhang Y, Chen Y.
    Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
    [Abstract] [Full Text] [Related]

  • 16. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
    Bandak SI, Bolzon LD, Turnak MR, Johns D, Henle SK, Allen BS.
    Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A, Cespedes J, Botet FA, Blumer J, Yogev R, Gesser R, Wang J, West J, Snyder T, Wimmer W, Protocol 036 Study Group.
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cephalexin: clinical effectiveness in geriatric patients.
    Smith IM.
    Geriatrics; 1977 Mar; 32(3):91-5, 99. PubMed ID: 844692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.